Disease/Infection News

RSS

New modeling study evaluates impact of COVID-19 in low- and middle-income countries

A new modeling study evaluating unfolding COVID-19 epidemics among different income countries reports that, in lower income countries, even if risk is reduced because populations are younger, this benefit is largely negated by limited health system capacity and closer inter-generational contact.

12 Jun 2020

GMU researcher evaluating COVID-19 mitigation strategies for H-2A farm workers

Leigh McCue-Weil, Associate Professor, Mechanical Engineering, is working with researchers at the Northeast Center for Occupational Health and Safety to develop a computationally efficient model of viral spread that can be utilized to better understand the effectiveness of disease spread mitigation strategies for H-2A farm workers living in employee housing.

12 Jun 2020

Beta adrenergic agonists can help decrease risk of graft vs. host disease in alloBMT recipients

New preclinical work by a team of researchers from Roswell Park Comprehensive Cancer Center's Transplant and Cellular Therapy Program suggests that the risk of developing acute graft vs. host disease during allogeneic blood/marrow transplant - a potentially curative treatment for selected patients with hematologic disorders - can be decreased using an existing class of drugs called beta adrenergic agonists.

12 Jun 2020

COVID-19 outbreak likely to worsen in Brazil, says GlobalData

Recently, Brazil has steadily climbed the chart of the top 10 countries with the highest total of COVID19 cases, now ranking number two just behind the US.

12 Jun 2020

China’s centralized and efficient command system helped win war against COVID-19

China’s centralized and efficient command system formed a strong guarantee for the country to win the all-out people's war against COVID-19, according to a recently-released government white paper.

12 Jun 2020

Survey: UK public understand that fast-tracking COVID-19 treatments could bring greater risks

The majority of the British public understand that fast-tracking vaccines, treatments and tests for COVID-19 could bring greater risks, according to a survey commissioned by law firm Hill Dickinson’s Life Sciences practice.

12 Jun 2020

If you’ve lost your health plan in the COVID crisis, you’ve got options

The coronavirus pandemic — and the economic fallout that has come with it — boosted health insurance enrollment counselor Mark Van Arnam's workload. But he wants to be even busier.

12 Jun 2020

Drug-like molecules offer a promising treatment for COVID-19

A team of researchers at the University of Georgia has successfully demonstrated that a set of drug-like small molecules can block the activity of a key SARS-CoV-2 protein - providing a promising path for new COVID-19 therapeutics.

12 Jun 2020

Facemasks will prevent COVID-19 in the "new normal"

The coronavirus disease (COVID-19) has left many countries grappling with high infection rates. The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has negatively impacted societies and economies. Now though, many countries are starting to lift restrictions to prepare for a "new normal."

12 Jun 2020

New experiment could help attenuate inflammatory reactions during severe Covid-19 cases

The fourth parabolic flight organized by the UZH Space Hub takes off today from Dübendorf airfield. A reorganization taking into account Corona safety measures has made this possible.

12 Jun 2020

COVID-19 triage strategies should focus on saving lives, argues bioethicist

How do we decide which patients with COVID-19 should get priority for lifesaving ventilators and ICU beds?

12 Jun 2020

Interferons being tested for COVID-19 may increase susceptibility to bacterial infections

Two separate studies in mice suggest that a class of interferons being evaluated in clinical trials as a therapy for COVID-19 may increase susceptibility to bacterial infections, depending on how long patients are exposed to it, and when they receive it.

12 Jun 2020

Study: Only a minority of Geneva population has been infected by Covid-19 pandemic

A study carried out among 2'766 people by the University Hospitals of Geneva (HUG), the Geneva Centre for Emerging Viral Diseases, and the University of Geneva (UNIGE), Switzerland, reveals that, at the time of the decline of the Coronavirus pandemic, only 10.8% of the Geneva population had been infected with Covid-19.

12 Jun 2020

Study initiates hydroxychloroquine clinical trial to prevent COVID-19 in healthy people

Rush University Medical Center has opened enrollment for a new clinical trial investigating whether the drug hydroxychloroquine is better than a placebo in preventing COVID-19 infection in healthy people working in health care settings.

12 Jun 2020

Researchers are developing statistical tools to analyze the spread and evolution of coronavirus

For as much as the scientific community has learned about the novel coronavirus, SARS-CoV-2, since it emerged in China last year, many key aspects of the pandemic remain a mystery.

12 Jun 2020

Contributions on IASS website address Covid-19 pandemic

The covid-19 pandemic remains an important topic throughout the world. A number of contributions on the IASS website address the pandemic and its consequences from the perspective of sustainability. We would be happy to put you in contact with the respective authors.

12 Jun 2020

PCR Biosystems launches new kit for ultra-sensitive, high-throughput detection of SARS-CoV-2

PCR Biosystems, the UK-based PCR experts, today announced the launch of qPCRBIO Probe 1-Step Virus Detect, a high-concentration 4x RT-qPCR kit designed specifically for ultra-sensitive, high-throughput detection of viral RNA sequences, including SARS-CoV-2.

12 Jun 2020

Type III interferons can increase risk of bacterial "superinfections" in the lung, research shows

Interferons and other cytokines produced by the immune system are important defenses against viral infections, but as we have seen in COVID-19, they can also contribute to damaging, potentially life-threatening lung inflammation.

12 Jun 2020

New, reliable tests identified for detecting antibodies specific to SARS-CoV-2

A new analysis of blood sera taken from 63 COVID-19 patients, 71 controls, and various coronavirus-exposed animals provides strong support for the use of the SARS-CoV-2 virus' receptor-binding domain (RBD) as an antigen for reliable tests to detect antibodies to the virus.

12 Jun 2020

MIT study examines which businesses should be open or closed during Covid-19 crisis

Banks and bookstores. Gyms and juice bars. Dental offices and department stores. The Covid-19 crisis has shuttered some kinds of businesses, while others have stayed open. But which places represent the best and worst tradeoffs, in terms of the economic benefits and health risks?

12 Jun 2020

Disease/Infection News

New modeling study evaluates impact of COVID-19 in low- and middle-income countries

GMU researcher evaluating COVID-19 mitigation strategies for H-2A farm workers

Beta adrenergic agonists can help decrease risk of graft vs. host disease in alloBMT recipients

COVID-19 outbreak likely to worsen in Brazil, says GlobalData

China’s centralized and efficient command system helped win war against COVID-19

Survey: UK public understand that fast-tracking COVID-19 treatments could bring greater risks

If you’ve lost your health plan in the COVID crisis, you’ve got options

Drug-like molecules offer a promising treatment for COVID-19

Facemasks will prevent COVID-19 in the "new normal"

New experiment could help attenuate inflammatory reactions during severe Covid-19 cases

COVID-19 triage strategies should focus on saving lives, argues bioethicist

Interferons being tested for COVID-19 may increase susceptibility to bacterial infections

Study: Only a minority of Geneva population has been infected by Covid-19 pandemic

Study initiates hydroxychloroquine clinical trial to prevent COVID-19 in healthy people

Researchers are developing statistical tools to analyze the spread and evolution of coronavirus

Contributions on IASS website address Covid-19 pandemic

PCR Biosystems launches new kit for ultra-sensitive, high-throughput detection of SARS-CoV-2

Type III interferons can increase risk of bacterial "superinfections" in the lung, research shows

New, reliable tests identified for detecting antibodies specific to SARS-CoV-2

MIT study examines which businesses should be open or closed during Covid-19 crisis

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News